<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
(Mark One)
(x) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarter ended June 30, 1995
OR
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ______________
Commission file number 0-11625
- --------------------------------------------------------------------------------
MICROFLUIDICS INTERNATIONAL CORPORATION
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 04-2793022
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
30 Ossipee Road, P.O. Box 9101, Newton, Massachusetts 02164
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(617) 969-5452
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
--- ---
Registrant had 5,052,082 shares of Common Stock, par value $.0l per share,
outstanding on August 9, 1995.
<PAGE>
This Amendment No. 1 on FORM 10-Q/A is being filed for the purpose of adding
Exhibit 27 to the FORM 10-Q of Microfluidics International Corporation for the
quarter ended June 30, 1995, which was filed with the Securities and Exchange
Commission on paper in August 1995 and electronically in April 1996.
<PAGE>
MICROFLUIDICS INTERNATIONAL CORPORATION
<TABLE>
<CAPTION>
PAGE
INDEX NUMBER
<S> <C>
PART I. Financial Information
ITEM 1. Financial Statements
Consolidated Balance Sheets as of June 30 3
1995 and December 31, 1994
Consolidated Statements of Operations 5
for the three and six months ended June 30, 1995 and 1994
Consolidated Statements of Cash Flows 6
for the six months ended June 30, 1995 and 1994
Notes to Financial Statements 7
ITEM 2. Management's Discussion and Analysis of 8
Financial Condition and Results of Operations
PART II. Other Information
ITEM 4. Submission of Matters to a Vote of Security 10
Holders
ITEM 6. Exhibits and Reports on Form 8-K 10
Exhibit 27 - Financial Data Schedule 12
</TABLE>
<PAGE>
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
Exhibit 27 - Financial Data Schedule
(b) Reports on Form 8-K
No reports on Form 8-K were filed during the period covered by
this report.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MICROFLUIDICS INTERNATIONAL CORPORATION
/s/ Michael A. Lento
--------------------------------------
Michael A. Lento
President and Treasurer
Date: May 21, 1996
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
MICROFLUIDICS INTERNATIONAL CORPORATION'S FORM 10-Q FOR THE QUARTER ENDED
JUNE 30, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-START> JAN-01-1995
<PERIOD-END> JUN-30-1995
<CASH> 2,219,784
<SECURITIES> 140,648
<RECEIVABLES> 1,893,555
<ALLOWANCES> 0
<INVENTORY> 2,749,699
<CURRENT-ASSETS> 7,372,775
<PP&E> 573,897
<DEPRECIATION> 441,137
<TOTAL-ASSETS> 8,786,629
<CURRENT-LIABILITIES> 821,686
<BONDS> 0
0
0
<COMMON> 50,347
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 8,786,629
<SALES> 0
<TOTAL-REVENUES> 3,000,169
<CGS> 1,346,087
<TOTAL-COSTS> 3,184,834
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (141,042)
<INCOME-TAX> (11,000)
<INCOME-CONTINUING> (152,042)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (152,042)
<EPS-PRIMARY> (.03)
<EPS-DILUTED> (.03)
</TABLE>
